Racial differences in breast cancer trends in the United States (2000-2004)

Journal of the National Cancer Institute

Volumn 100, Issue 10, 2008, Pages 751-752

  Pfeiffer, Ruth M ^a   Mitani, Aya ^b   Matsuno, Rayna K ^a   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; HORMONE SUBSTITUTION; HUMAN; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; ADULT; AFRICAN AMERICAN; AGE; AGED; ASIAN AMERICAN; BREAST TUMOR; CAUCASIAN; CHEMISTRY; ESTROGEN THERAPY; ETHNOLOGY; FEMALE; HISPANIC; INCIDENCE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTOR; STATISTICS; WOMEN'S HEALTH;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; ASIAN AMERICANS; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; MIDDLE AGED; OBESITY; PREVALENCE; RECEPTORS, ESTROGEN; RISK FACTORS; SEER PROGRAM; UNITED STATES; WOMEN'S HEALTH;

EID: 44449174563     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn112     Document Type: Letter

References (7)

1. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356(16):1670-1674.
2. Hausauer AK, Keegan TH, Chang ET, Clarke CA. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res. 2007;9(6):R90.
3. Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2773-2780.
4. Breen N, A Cronin K, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007;109(12):2405-2409.
5. Wei F, Miglioretti DL, Connelly MT, et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr. 2005;35:106-112.
6. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283(4):485-491.
7. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.